Literature DB >> 34406038

The View from the Benches: Scientists' Perspectives on the Uses and Governance of Human Gene-Editing Research.

Margaret Waltz1, Eric T Juengst1, Teresa Edwards2, Gail E Henderson1, Kristine J Kuczynski1, John M Conley3, Paige Della-Penna4, R Jean Cadigan1.   

Abstract

The advent of human gene editing has stimulated international interest in how best to govern this research. However, research on stakeholder views has neglected scientists themselves. We surveyed 212 scientists who use gene editing in their work. Questions captured views on oversight and use of somatic and germline human gene editing for treatment, prevention, and enhancement. More respondents were supportive of somatic than germline editing, and more supported gene editing for treatment compared to prevention. Few supported its use for enhancement. When presented with specific conditions, levels of support for somatic editing differed by type of condition. Almost all respondents said scientists and national government representatives should be involved in oversight, but only 28% said scientists are best positioned to oversee gene-editing research. These results can inform the development of sound approaches to research governance, demonstrating the importance of identifying specific gene-editing uses when considering oversight.

Entities:  

Mesh:

Year:  2021        PMID: 34406038      PMCID: PMC8392077          DOI: 10.1089/crispr.2021.0038

Source DB:  PubMed          Journal:  CRISPR J        ISSN: 2573-1599


  15 in total

1.  Adopt a moratorium on heritable genome editing.

Authors:  Eric S Lander; Françoise Baylis; Feng Zhang; Emmanuelle Charpentier; Paul Berg; Catherine Bourgain; Bärbel Friedrich; J Keith Joung; Jinsong Li; David Liu; Luigi Naldini; Jing-Bao Nie; Renzong Qiu; Bettina Schoene-Seifert; Feng Shao; Sharon Terry; Wensheng Wei; Ernst-Ludwig Winnacker
Journal:  Nature       Date:  2019-03       Impact factor: 49.962

2.  Is Enhancement the Price of Prevention in Human Gene Editing?

Authors:  Eric T Juengst; Gail E Henderson; Rebecca L Walker; John M Conley; Douglas MacKay; Karen M Meagher; Katherine Saylor; Margaret Waltz; Kristine J Kuczynski; R Jean Cadigan
Journal:  CRISPR J       Date:  2018-11-26

3.  Human germline gene editing: Recommendations of ESHG and ESHRE.

Authors:  Guido de Wert; Guido Pennings; Angus Clarke; Ursula Eichenlaub-Ritter; Carla G van El; Francesca Forzano; Mariëtte Goddijn; Björn Heindryckx; Heidi C Howard; Dragica Radojkovic; Emmanuelle Rial-Sebbag; Basil C Tarlatzis; Martina C Cornel
Journal:  Eur J Hum Genet       Date:  2018-01-12       Impact factor: 4.246

4.  Public Acceptability of Gene Therapy and Gene Editing for Human Use: A Systematic Review.

Authors:  Juliette Delhove; Ivana Osenk; Ivanka Prichard; Martin Donnelley
Journal:  Hum Gene Ther       Date:  2020-01       Impact factor: 5.695

5.  Attitudes of Members of Genetics Professional Societies Toward Human Gene Editing.

Authors:  Alyssa J Armsby; Yvonne Bombard; Nanibaa' A Garrison; Bonnie L Halpern-Felsher; Kelly E Ormond
Journal:  CRISPR J       Date:  2019-10

6.  Human Germline Genome Editing: An Assessment.

Authors:  Henry T Greely
Journal:  CRISPR J       Date:  2019-10

7.  Attitudes Toward Hypothetical Uses of Gene-Editing Technologies in Parents of People with Autosomal Aneuploidies.

Authors:  Erika Snure Beckman; Natalie Deuitch; Marsha Michie; Megan A Allyse; Kirsten A Riggan; Kelly E Ormond
Journal:  CRISPR J       Date:  2019-10

8.  Where Will We Draw the Line? Public Opinions of Human Gene Editing.

Authors:  Kirsten A Riggan; Richard R Sharp; Megan Allyse
Journal:  Qual Health Res       Date:  2019-05-05

9.  Global citizen deliberation on genome editing.

Authors:  John S Dryzek; Dianne Nicol; Simon Niemeyer; Sonya Pemberton; Nicole Curato; André Bächtiger; Philip Batterham; Bjørn Bedsted; Simon Burall; Michael Burgess; Gaetan Burgio; Yurij Castelfranchi; Hervé Chneiweiss; George Church; Merlin Crossley; Jantina de Vries; Mahmud Farooque; Marit Hammond; Baogang He; Ricardo Mendonça; Jennifer Merchant; Anna Middleton; John E J Rasko; Ine Van Hoyweghen; Antoine Vergne
Journal:  Science       Date:  2020-09-18       Impact factor: 47.728

10.  Do CRISPR Germline Ethics Statements Cut It?

Authors:  Carolyn Brokowski
Journal:  CRISPR J       Date:  2018-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.